PC

Prashanth Chinthapally

Active Director Additional Director DIN 09761561
DIN 09761561 First appointment Oct 2022 Primary industry Electrnoics
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Oct 2022
Shareholding value β€’β€’β€’β€’ Premium profile

About Prashanth Chinthapally

Data last updated:

Prashanth Chinthapally is an Additional Director at Speranza Pharma Private Limited (since 2022). The company operates in Electrnoics.

DIN 09761561
Primary Designation Additional Director
Industry Electrnoics
First Appointment 11 Oct 2022
Oldest Company Age 9 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Speranza Pharma Private Limited U52609TG2016PTC113238
Additional Director11 Oct 20222016Active

Board colleagues of Prashanth Chinthapally

NameDINCompanyDesignation
Rasad Mahammad07658723Speranza Pharma Private LimitedDirector

Directorship timeline

Open interactive timeline →
Speranza Pharma Private Limited
Premium access

Shareholding and investment profile for Prashanth Chinthapally

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Prashanth Chinthapally

Prashanth Chinthapally currently holds 1 directorship: Speranza Pharma Private Limited (Additional Director, since 11 Oct 2022).

Prashanth Chinthapally was first appointed on 11 Oct 2022 as Additional Director at Speranza Pharma Private Limited.

The current boards of Prashanth Chinthapally's companies include Rasad Mahammad (Speranza Pharma Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available